India: Healthcare scrips Alkem, Dr Lal Pathlabs list at robust premium on debut

India: Healthcare scrips Alkem, Dr Lal Pathlabs list at robust premium on debut

Visual from Alkem Labs website

Shares of healthcare firms Alkem Laboratories Ltd and Dr Lal Pathlabs Ltd, opened 31.43% and 30.4% higher from their respective issue price of Rs.1,050 and Rs.550 per share, following their successful initial public offering (IPO) earlier this month.

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter